<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="project_funders\PMC6749704\results\search\funders\results.xml">
  <result pre="J.alexander.thompson@svhm.org.au34BarnesEleanorellie.barnes@ndm.ox.ac.uk56El-SayedManalmanalhelsayed@yahoo.co.uk7BenzakenAdele Schwartzadelebenz@gmail.com8DrummerHeidi E.heidi.drummer@burnet.edu.au1910HellardMargaret E.margaret.hellard@burnet.edu.au121011[1], 0000 0001 2224 8486grid.1056.2Disease Elimination Program," exact="Burnet Institute," post="[2], 0000 0004 1936 7857grid.1002.3Department of Epidemiology and Preventive"/>
  <result pre="[2], 0000 0004 1936 7857grid.1002.3Department of Epidemiology and Preventive Medicine," exact="Monash University," post="[3], 0000 0001 2179 088Xgrid.1008.9Department of Medicine, The University"/>
  <result pre="Monash University, [3], 0000 0001 2179 088Xgrid.1008.9Department of Medicine, The" exact="University of Melbourne," post="[4], 0000 0000 8606 2560grid.413105.2Department of Gastroenterology, St Vincent’s"/>
  <result pre="University NHS Trust, [7], 0000 0004 0621 1570grid.7269.aDepartment of Paediatrics," exact="Ain Shams University," post="[8], [9], 0000 0004 1936 7857grid.1002.3Department of Microbiology, Monash"/>
  <result pre="Shams University, [8], [9], 0000 0004 1936 7857grid.1002.3Department of Microbiology," exact="Monash University," post="[10], 0000 0001 2179 088Xgrid.1008.9Peter Doherty Institute for Infection"/>
  <result pre="0001 2179 088Xgrid.1008.9Peter Doherty Institute for Infection and Immunity, The" exact="University of Melbourne," post="[11], 0000 0004 0432 511Xgrid.1623.6Department of Infectious Diseases, The"/>
  <result pre="0004 0432 511Xgrid.1623.6Department of Infectious Diseases, The Alfred Hospital and" exact="Monash University," post="epub: 2019-9-9pmc-release: 2019-9-9collection: 201917175received: 2019-4-15accepted: 2019-8-19(C) , Open AccessThis"/>
  <result pre="Elimination Hepatitis C Mathematical model Vaccine Funding http://dx.doi.org/10.13039/501100000925National Health and" exact="Medical Research Council" post="APP1132902HellardMargaret E. Background There are vast differences in the"/>
  <result pre="across the globe that have significant implications for meeting the" exact="World Health Organization" post="(WHO) 2030 hepatitis C elimination targets. A consequence is"/>
  <result pre="inject drugs RNA Ribonucleic acid US$ United States dollar WHO" exact="World Health Organization" post="Publisher’s Note Springer Nature remains neutral with regard to"/>
  <result pre="authors. Acknowledgements MH, DW, and HD are the recipients of" exact="National Health and Medical Research Council" post="fellowships and grant funding. EB is funded by the"/>
  <result pre="DW, and HD are the recipients of National Health and" exact="Medical Research Council" post="fellowships and grant funding. EB is funded by the"/>
  <result pre="Council fellowships and grant funding. EB is funded by the" exact="Medical Research Council" post="UK and the Oxford NIHR Biomedical Research Centre and"/>
  <result pre="not necessarily those of the NHS, the NIHR, or the" exact="Department of Health." post="The authors gratefully acknowledge the support provided to the"/>
  <result pre="Health. The authors gratefully acknowledge the support provided to the" exact="Burnet Institute" post="by the Victorian Government Operational Infrastructure Support Program. Authors’"/>
  <result pre="final manuscript. Funding This study was funded by the Australian" exact="National Health and Medical Research Council." post="The funders had no role in study design, data"/>
  <result pre="This study was funded by the Australian National Health and" exact="Medical Research Council." post="The funders had no role in study design, data"/>
  <result pre="Not applicable Competing interests NS receives investigator-initiated research funding from" exact="Gilead Sciences" post="unrelated to this work. AT is an advisory board"/>
  <result pre="to this work. AT is an advisory board member for" exact="Gilead Sciences," post="AbbVie, BMS, Merck, and Roche Diagnostics and a speaker"/>
  <result pre="advisory board member for Gilead Sciences, AbbVie, BMS, Merck, and" exact="Roche" post="Diagnostics and a speaker for Gilead, Merck, BMS, AbbVie,"/>
  <result pre="Diagnostics and a speaker for Gilead, Merck, BMS, AbbVie, and" exact="Roche" post="Diagnostics. EB is developing vaccines as part of an"/>
  <result pre="vaccines that encode class II invariant chain. MH and the" exact="Burnet Institute" post="receive investigator-initiated research funding from Gilead Sciences, AbbVie, and"/>
  <result pre="MH and the Burnet Institute receive investigator-initiated research funding from" exact="Gilead Sciences," post="AbbVie, and BMS. References References 1.ShepardCWFinelliLAlterMJGlobal epidemiology of hepatitis"/>
 </snippets>
</snippetsTree>
